Last updated: August 6, 2021
Sponsor: N/A
Overall Status: Active - Recruiting
Phase
N/A
Condition
Prostate Cancer
Treatment
N/AClinical Study ID
TX279281
Ages 18-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Are a male or female at least 18 years of age
- Have histologically or cytologically confirmed adenocarcinoma of the prostate
- Have metastatic prostate cancer disease
- Are surgically or medically castrated
- Have had no prior treatment with cytotoxic chemotherapy
- Demonstrate adequate organ function
Exclusion
Exclusion Criteria:
- Have known symptomatic brain metastases.
- Have clinically significant cardiovascular disease
- Have untreated or impending spinal cord compression
- Have a severe concurrent disease, infection, or comorbidity
- Have a history of seizure
- Have had major surgery within 4 weeks
- Have known immunodeficiency virus (HIV) infection, hepatitis B or C
Study Design
Study Start date:
August 06, 2021
Estimated Completion Date:
Study Description
Connect with a study center
Biomedical Research Alliance of New York
Bronx, New York 10461
United StatesActive - Recruiting
Biomedical Research Alliance of New York LLC
Bronx, New York 10461
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.